Clinical Trials in Ohio

Showing 6781-6800 of 20,938 trials

Young Adult EC Use and Respiratory Outcomes

NCT04395274

E-cigarette (EC) use continues to increase among youth, and EC may be detrimental to youth respiratory health. Public health officials and the Food and Drug Administration (FDA) can now regulate ECs. The proposed study uses naturalistic assessments called ecological momentary assessment (EMA) to understand how ECs use may impact the respiratory health of youth and young adult users compared to never-using peers.

E Cig Use

Ohio State University Comprehensive Cancer Center115 participantsStarted Dec 2021

Columbus, Ohio, United States

TERMINATEDPhase 232 miles

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

NCT03640481

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy

Chronic Graft-versus-host-disease

Kadmon, a Sanofi Company159 participantsStarted Oct 2018

Phoenix, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +32 more locations

Young Adult EC Use and Respiratory Outcomes

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Find Trials by Condition in Ohio

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Comprehensive Outcomes for After Cancer Health

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Osia 2 Pediatric Expansion Study

Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Study of ATH434 in Participants with Multiple System Atrophy

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

AAV Gene Therapy Study for Subjects with PKU

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD